The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling
about
sameAs
Immune Cells in Cancer Therapy and Drug DeliveryLymphoma Immunotherapy: Current StatusCTLA-4 blockade in tumor models: an overview of preclinical and translational researchIs There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsAnti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.Combination immunotherapy with 4-1BBL and CTLA-4 blockade for the treatment of prostate cancerCTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion.Immunomodulatory therapy for melanoma: ipilimumab and beyondA phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicineImmunocombination therapy for high-risk neuroblastoma.Active immunotherapy: current state of the art in vaccine approaches for NHLImmune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.Immuno-regulatory antibodies for the treatment of cancer.Immune checkpoint inhibitor combinations in solid tumors: opportunities and challengesInduction of Bcl-xL-specific cytotoxic T lymphocytes in mice.New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone.Ipilimumab for the treatment of metastatic prostate cancer.Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors.
P2860
Q26747061-5182878F-38DA-4B23-BC7B-870079AD2D6BQ26782902-27BBE743-098C-4BC2-9544-BC63B769B66AQ26992295-6563E203-4AFD-49DE-AE03-016A03858BCDQ28072532-3EB2A08C-5C47-4C2D-A1C4-F49DC02B9F7CQ34405616-65AC9473-9BFF-42E7-95BF-1F6979B4D042Q34658452-1056C1D7-C324-4095-AE27-CB3A1AC0667EQ35664913-18827F6A-EE24-4E8E-B33B-2B198435E46EQ35726637-1929E8F9-8A9C-462A-88A8-B5925FB5B8FFQ35945339-DE39C3E4-2A14-4003-A698-DA16EF03A21CQ36841621-5F7BCA35-69B2-4A85-B02F-389509C01230Q37038104-85989DFF-58C6-4762-A7A1-DB9F074A9ED5Q37224420-A21A0652-5B2D-4ED8-8679-1C5BFE63E687Q37991024-CF01586D-030D-4C8C-9CD2-D6390673F503Q38030484-CCFCFF35-7745-463F-97B3-4E6273FEE901Q38161367-DF638CAE-91ED-43A2-B84D-22FEE69D4B4EQ38424617-CD60C94B-364F-4490-ACBE-58900C935460Q38878906-A652295F-E186-441B-9203-781CE06D2613Q38993215-83680778-37E1-4D4A-BB11-88C426F4520AQ46047154-81649103-547F-427E-9E28-D7AF8385236CQ47225399-65C65BB2-D43B-4CCC-AC7D-37E246767D27Q54976860-0DF32FB6-DDD2-4133-B454-F24712ACE5CA
P2860
The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling
description
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@en
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@nl
type
label
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@en
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@nl
prefLabel
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@en
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@nl
P2093
P50
P1433
P1476
The effect of a therapeutic de ...... e blockage of CTLA-4 signaling
@en
P2093
Mingjun Wang
Mogens H Claesson
Mogens H Nissen
P304
P356
10.1016/J.CANLET.2005.02.005
P407
P577
2006-01-01T00:00:00Z